Abstract
Expression levels of five miRNAs (miR-19b, miR-21, miR-126, miR-141, miR-205) were measured in the plasma of healthy donors and prostate cancer patients. It was shown that miR-141 expression level efficiently discriminates early stage prostate cancer patients and correlates with the Gleason score.
Keywords:
Biomarkers; Prostate cancer; miRNA.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biomarkers, Tumor / blood
-
Biomarkers, Tumor / genetics*
-
Cohort Studies
-
Diagnosis, Differential
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Logistic Models
-
Male
-
MicroRNAs / blood
-
MicroRNAs / genetics*
-
Neoplasm Grading
-
Neoplasm Staging
-
Prostatic Neoplasms / blood
-
Prostatic Neoplasms / diagnosis
-
Prostatic Neoplasms / genetics*
-
Reverse Transcriptase Polymerase Chain Reaction
-
Sensitivity and Specificity
-
Up-Regulation
Substances
-
Biomarkers, Tumor
-
MIRN141 microRNA, human
-
MIRN205 microRNA, human
-
MicroRNAs